Ren et al. [110] demonstrated that ginsenoside Rg3 prevents angiotensin II- (Ang II-) induced myocardial hypertrophy via inactivating NLRP3 inflammasome and oxidative stress by modulating the NF-κB pathway. The gene discussed is AGT; the disease is cardiac hypertrophy.